BioVaxys Technology Corp.
BVAXF
$0.0229
$0.00031.33%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.41% | 12.67% | 49.32% | 74.27% | 56.22% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.47% | -21.58% | -55.09% | -85.00% | -72.12% |
| Change in Net Operating Assets | -64.16% | -100.61% | -97.30% | -30.08% | 40.91% |
| Cash from Operations | -394.40% | -267.37% | -74.94% | 33.46% | 65.25% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.53% | -- | -- | -- | -- |
| Cash from Investing | 4.53% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -- | -- | -- | -- |
| Issuance of Common Stock | 93.61% | 86.50% | 244.63% | 89.91% | 32.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 89.48% | 80.75% | 239.20% | 90.60% | 31.91% |
| Foreign Exchange rate Adjustments | 185.00% | -26.67% | 170.83% | 106.51% | 84.25% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -208.60% | -189.83% | 251.20% | 1,414.49% | 255.04% |